Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

FEMASYS INC

FEMY · Nasdaq · CIK 0001339005 · Healthcare · Medical Instruments & Supplies

INSIDER SIGNAL

69.7 / 100

5 buyers · 5 purchase transaction lines · $134.0K gross purchase

WHY THIS SIGNAL?

Buyer breadthStrong
Purchase sizeLow
RoleModerate
RecencyLow
ConvictionStrong
Score anatomy

Each bar shows the contribution to the current score; the weights and formula stay unchanged.

Cluster+35.0 / 35
Purchase size+8.7 / 25
Role+13.0 / 20
Recency+3.0 / 10
Conviction+10.0 / 10

What is holding the score back?

  • ⚠ Purchase size is modest relative to the model scale
  • ⚠ Role scores low · most senior buyer: Chief Executive Officer (CEO, chair and 10% owners score lowest)
  • ⚠ Purchase activity is becoming less recent
  • ✓ Cluster breadth is broad · 4+ insiders

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 ranks qualifying equity purchases under the current 180-day rules. The score is a research priority, not a return forecast or probability. Backtests have not shown that a higher US score is followed by better returns.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Mifek Jeffrey GeraldChief Clinical-Medical Affairs
●
Sipos Jeremy AlexanderChief Technology Officer
●
Canning John CharlesChief Operating Officer
●
Elefant DovChief Financial Officer
●
Lee-Sepsick KathyChief Executive Officer
●
● Purchase▼ Sale○ Other

—

Purchase breadth & concentration

QUALIFYING BUYERS5
PURCHASE CONCENTRATION37%Largest buyer: Elefant Dov · $50.0K
CLUSTER BUYING · 15D5 insidersPeak activity: 2026-08-07–2026-08-07

Roles in the peak window: Chief Clinical-Medical Affairs, Chief Executive Officer, Chief Financial Officer, Chief Operating Officer, Chief Technology Officer. Concentration uses priced qualifying P lines only and does not change the saved score.

SIGNAL HISTORY

69.7 / 100

Latest recorded score

↓ -0.1 ptsversus the previous recorded snapshot
  1. 70.0
  2. 69.9
  3. 69.9
  4. 69.8
  5. 69.7

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

Recent Form 4 activity

5Purchases
0Sales
0Other Form 4 lines
5SEC filings · 365 days
BUYING5 qualifying P line(s) · 180 days
SELLING0 sale line(s) · context only
OTHER0 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.

Price performance

1M
-27.0%
3M
-42.4%
6M
-74.8%
12M
-83.2%

Volatility & liquidity

Volatility
109.9%
Beta
—
Avg daily value
USD 1.5M

Valuation

Market cap
USD 16.8M
P/E
—

Fundamentals

Profit margin
-812.3%
ROE
-317.4%
Industry
Medical Instruments & Supplies

Market data

Price data up to: 2026-10-11 · Price source: OpenBB/yfinance; volume from price cache (yfinance) · From SEC filings: Market cap, Profit margin, ROE · Fiscal year ended: 2025-12-31 · Market cap is the shares outstanding stated on the filing cover multiplied by the latest close. Share count date: 2026-08-13 · Status: PASS

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
577,249
Previous report
612,619
Avg daily volume
78,475
Days to cover
7.4

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-07Sipos Jeremy AlexanderPurchase (P)Common Stock3,125USD 3.20USD 10,000SEC filing ↗
2026-08-07Mifek Jeffrey GeraldPurchase (P)Common Stock3,125USD 3.20USD 10,000SEC filing ↗
2026-08-07Lee-Sepsick KathyPurchase (P)Common Stock15,625USD 3.20USD 50,000SEC filing ↗
2026-08-07Elefant DovPurchase (P)Common Stock15,625USD 3.20USD 50,000SEC filing ↗
2026-08-07Canning John CharlesPurchase (P)Common Stock4,375USD 3.20USD 14,000SEC filing ↗
2021-06-23Dyett JohnPurchase (P)Common Stock1,000USD 9.95USD 9,950SEC filing ↗
2021-06-22Uzialko Edward RPurchase (P)Common Stock100,000USD 13.00USD 1,300,000SEC filing ↗
2021-06-22Larsen CharlesPurchase (P)Common Stock7,000USD 13.00USD 91,000SEC filing ↗
2021-06-22Dyett JohnPurchase (P)Common Stock40,000USD 13.00USD 520,000SEC filing ↗
2021-06-22Adams John Q JRPurchase (P)Common Stock40,000USD 13.00USD 520,000SEC filing ↗
2021-06-18Dyett JohnPurchase (P)Common Stock12,500USD 12.94USD 161,750SEC filing ↗

Form 4 evidence

5 transaction lines in the latest 365-day window; 29 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-07Sipos Jeremy AlexanderPurchase (P)Common Stock3,125USD 3.20USD 10,000SEC filing ↗
2026-08-07Mifek Jeffrey GeraldPurchase (P)Common Stock3,125USD 3.20USD 10,000SEC filing ↗
2026-08-07Lee-Sepsick KathyPurchase (P)Common Stock15,625USD 3.20USD 50,000SEC filing ↗
Show recent Form 4 evidence (5 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-07Sipos Jeremy AlexanderPurchase (P)Common Stock3,125USD 3.20USD 10,000SEC filing ↗
2026-08-07Mifek Jeffrey GeraldPurchase (P)Common Stock3,125USD 3.20USD 10,000SEC filing ↗
2026-08-07Lee-Sepsick KathyPurchase (P)Common Stock15,625USD 3.20USD 50,000SEC filing ↗
2026-08-07Elefant DovPurchase (P)Common Stock15,625USD 3.20USD 50,000SEC filing ↗
2026-08-07Canning John CharlesPurchase (P)Common Stock4,375USD 3.20USD 14,000SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerFEMY
CIK0001339005
SectorHealthcare
IndustryMedical Instruments & Supplies Yahoo Finance
SEC SIC3841 Surgical & Medical Instruments & Apparatus
ExchangeNasdaq

Data coverage

Local Form 4 history29 transaction lines from 2021-06-18 to 2026-08-07
12 P purchase lines · 0 S sale lines · 17 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.